Lutetium-177-PSMA-617 (177Lu-PSMA-617), a type of targeted medlinkradiation therapy/medlink, is effective for men with advanced medlinkprostate

New research findings were reported today from the ENZA-p study (ANZUP 1901), led by the Australian and New Zealand Urogenital and Prostate Cancer...

Focused ultrasound therapy provides a non-invasive, promising treatment option for prostate cancer, offering hope with fewer side effects and...

A new study suggests that a combination of radiation therapy and immune checkpoint inhibitors (ICIs) may offer a less invasive alternative to bladder...

TUESDAY, Feb. 11, 2025 -- The 18-gene MyProstateScore 2.0 (MPS2) test using first-catch non-digital rectal examination (DRE) urine is highly...

Aston University is collaborating in research to develop an injectable paste which could treat bone cancer.

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious...

Dr Ramakant said, “Breast cancer should not be ignored in the early stages, and surgery is an effective treatment for curing the disease.”

Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

A new perspective published in The Lancet Oncology is challenging the way doctors and scientists understand and treat metastatic brain cancer....